Imricor Medical Systems, Inc.ASX: IMR

Imricor and Philips Launch Commercial iMR Lab Solution

· Issued by Imricor Medical Systems, Inc. via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Imricor Medical Systems, Inc. has announced the commercial launch of a new Interventional MR lab solution in collaboration with Philips, aimed at enhancing MR-guided cardiac interventions. The integrated solution combines Philips’ MRI platform with Imricor’s MR-compatible systems and tools, designed for cardiac procedures. The solution is immediately available in CE-marked markets and selected configurations are also available in the United States.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019 400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 | imricor.com IMRICOR AND PHILIPS LAUNCH COMMERCIAL IMR LAB SOLUTION Global collaboration advances MR-guided cardiac interventions toward...

Imricor Medical Systems, Inc. on 6ix

Story so far

Earlier from Imricor Medical Systems

Later from Imricor Medical Systems

All Imricor Medical Systems news releases